{"id":1527,"date":"2026-10-21T09:00:00","date_gmt":"2026-10-21T09:00:00","guid":{"rendered":"https:\/\/lee-pharm.com\/self-developed-product-treprostinil-injection-selected-for-the-%e3%80%8a2026-hefei-high-end-industrial-products-list%e3%80%8b\/"},"modified":"2026-10-21T10:32:06","modified_gmt":"2026-10-21T10:32:06","slug":"self-developed-product-treprostinil-injection-selected-for-the-%e3%80%8a2026-hefei-high-end-industrial-products-list%e3%80%8b","status":"publish","type":"post","link":"https:\/\/lee-pharm.com\/en\/self-developed-product-treprostinil-injection-selected-for-the-%e3%80%8a2026-hefei-high-end-industrial-products-list%e3%80%8b\/","title":{"rendered":"Self-Developed Product \u201cTreprostinil Injection\u201d Selected for the \u300a2026 Hefei High-End Industrial Products List\u300b"},"content":{"rendered":"

Recently, the Hefei Municipal Bureau of Industry and Information Technology released the “2026 Hefei High-end Industrial Products List”. Treprostinil Injection (\u201cThe Product\u201d, 20ml:20mg & 20ml:50mg), a self-developed product by Zhaoke Pharmaceutical (Hefei) Co., Ltd. (“Zhaoke Hefei”), a wholly-owned subsidiary of Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” or the “Group”, Stock Code: 00950), was successfully listed.<\/p>\n